Table IV.
Effect of different treatments on the expression levels of NF-κB in multiple organs at 3 h (pg/ml).
| Organ | C | SAP | SL | IU | UL |
|---|---|---|---|---|---|
| Pancreas | 3.198±0.295 | 4.424±0.153a | 3.716±0.266a,b | 4.254±0.166a | 3.574±0.297a,b |
| Lung | 4.543±0.349 | 6.821±0.276a | 5.215±0.300a,b | 5.890±0.359a,b | 4.856±0.285b,c |
| Liver | 3.489±0.257 | 6.250±0.384a | 3.781±0.276b,c | 4.766±0.334a,b | 3.793±0.223b,c |
| Kidney | 2.690±0.277 | 5.568±0.297a | 4.665±0.267a,b | 5.225±0.325a,d | 3.878±0.329a,b |
Values are presented as mean ± standard deviation.
a
P<0.01 vs. group C;
b
P<0.01 vs. group SAP;
c
P<0.05 vs. group C;
d
P<0.05 vs. group SAP. C, control; SAP, severe acute pancreatitis; SL, saline lavage; IU, intravenous ulinastatin; UL, ulinastatin lavage; NF-κB, nuclear factor-κB.